Jove
Visualize
Contact Us
JoVE
x logofacebook logolinkedin logoyoutube logo
ABOUT JoVE
OverviewLeadershipBlogJoVE Help Center
AUTHORS
Publishing ProcessEditorial BoardScope & PoliciesPeer ReviewFAQSubmit
LIBRARIANS
TestimonialsSubscriptionsAccessResourcesLibrary Advisory BoardFAQ
RESEARCH
JoVE JournalMethods CollectionsJoVE Encyclopedia of ExperimentsArchive
EDUCATION
JoVE CoreJoVE BusinessJoVE Science EducationJoVE Lab ManualFaculty Resource CenterFaculty Site
Terms & Conditions of Use
Privacy Policy
Policies

Filters

Eric L Simpson

Showing results (91-100 of 314) with videos related to

Pageof 32
Sort By:
European Journal of Dermatology : EJD|December 19, 2007
CD30 expression on CD1a+ and CD8+ cells in atopic dermatitis and correlation with disease severityEzogelin Oflazoglu, Eric L Simpson, Rodd Takiguchi, et al.
European Journal of Dermatology : EJD|August 12, 2008
CD40 expression on antigen presenting cells and correlation with disease severity in atopic dermatitisEzogelin Oflazoglu, Eric L Simpson, Rodd Takiguchi, et al.
Archives of Dermatological Research|August 30, 2024
Interleukin-1α inhibitor bermekimab in patients with atopic dermatitis: randomized and nonrandomized studiesEric L Simpson, Emma Guttman-Yassky, Jeffrey Pawlikowski, et al.
Dermatology and Therapy|January 7, 2022
Consistency of Response to Dupilumab in Adults with Moderate-to-Severe Atopic Dermatitis Over 1 YearAndrew Blauvelt, Marjolein de Bruin-Weller, Eric L Simpson, et al.
Dermatitis : Contact, Atopic, Occupational, Drug|March 23, 2022
Assessment and Monitoring Challenges Among Patients With Moderate-to-Severe Atopic Dermatitis Across Fitzpatrick Skin Types: A Photographic Review and Case SeriesValeria Aoki, Marilia Oliveira, Colleen Wegzyn, et al.
Journal of the American Academy of Dermatology|December 22, 2015
A systematic review of Investigator Global Assessment (IGA) in atopic dermatitis (AD) trials: Many options, no standardsMasaki Futamura, Yael A Leshem, Kim S Thomas, et al.
Pediatrics|November 19, 2008
Three times weekly tacrolimus ointment reduces relapse in stabilized atopic dermatitis: a new paradigm for useAmy S Paller, Lawrence F Eichenfield, Robert S Kirsner, et al.
Dermatology and Therapy|July 12, 2024
Ruxolitinib Cream in Adolescents/Adults with Atopic Dermatitis Meeting Severity Thresholds for Systemic Therapy: Exploratory Analysis of Pooled Results from Two Phase 3 StudiesEric L Simpson, Leon Kircik, Andrew Blauvelt, et al.
Journal of the American Academy of Dermatology|June 15, 2007
Cutaneous responses to vaccinia in individuals with previous smallpox vaccinationEric L Simpson, Michelle Hercher, Erika K Hammarlund, et al.
Vaccine|December 18, 2007
Traditional smallpox vaccination with reduced risk of inadvertent contact spread by administration of povidone iodine ointmentErika Hammarlund, Matthew W Lewis, Jon M Hanifin, et al.
Pageof 32

Showing results (91-100 of 314) with videos related to

Sort By:
Pageof 32
European Journal of Dermatology : EJD|December 19, 2007
CD30 expression on CD1a+ and CD8+ cells in atopic dermatitis and correlation with disease severityEzogelin Oflazoglu, Eric L Simpson, Rodd Takiguchi, et al.
European Journal of Dermatology : EJD|August 12, 2008
CD40 expression on antigen presenting cells and correlation with disease severity in atopic dermatitisEzogelin Oflazoglu, Eric L Simpson, Rodd Takiguchi, et al.
Archives of Dermatological Research|August 30, 2024
Interleukin-1α inhibitor bermekimab in patients with atopic dermatitis: randomized and nonrandomized studiesEric L Simpson, Emma Guttman-Yassky, Jeffrey Pawlikowski, et al.
Dermatology and Therapy|January 7, 2022
Consistency of Response to Dupilumab in Adults with Moderate-to-Severe Atopic Dermatitis Over 1 YearAndrew Blauvelt, Marjolein de Bruin-Weller, Eric L Simpson, et al.
Dermatitis : Contact, Atopic, Occupational, Drug|March 23, 2022
Assessment and Monitoring Challenges Among Patients With Moderate-to-Severe Atopic Dermatitis Across Fitzpatrick Skin Types: A Photographic Review and Case SeriesValeria Aoki, Marilia Oliveira, Colleen Wegzyn, et al.
Journal of the American Academy of Dermatology|December 22, 2015
A systematic review of Investigator Global Assessment (IGA) in atopic dermatitis (AD) trials: Many options, no standardsMasaki Futamura, Yael A Leshem, Kim S Thomas, et al.
Pediatrics|November 19, 2008
Three times weekly tacrolimus ointment reduces relapse in stabilized atopic dermatitis: a new paradigm for useAmy S Paller, Lawrence F Eichenfield, Robert S Kirsner, et al.
Dermatology and Therapy|July 12, 2024
Ruxolitinib Cream in Adolescents/Adults with Atopic Dermatitis Meeting Severity Thresholds for Systemic Therapy: Exploratory Analysis of Pooled Results from Two Phase 3 StudiesEric L Simpson, Leon Kircik, Andrew Blauvelt, et al.
Journal of the American Academy of Dermatology|June 15, 2007
Cutaneous responses to vaccinia in individuals with previous smallpox vaccinationEric L Simpson, Michelle Hercher, Erika K Hammarlund, et al.
Vaccine|December 18, 2007
Traditional smallpox vaccination with reduced risk of inadvertent contact spread by administration of povidone iodine ointmentErika Hammarlund, Matthew W Lewis, Jon M Hanifin, et al.
Pageof 32